Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | C-TIL051 |
Trade Name | |
Synonyms | CTIL051|C TIL051 |
Drug Descriptions |
C-TIL051 are tumor-derived autologous tumor infiltrating lymphocytes (TILs), which induce killing of tumor cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C199290 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Aldesleukin + C-TIL051 + Pembrolizumab | Aldesleukin C-TIL051 Pembrolizumab | 0 | 1 |
C-TIL051 | C-TIL051 | 0 | 0 |